CD8A and neoplasm: The ratio of intra-tumoral granzyme B+CD8+ T cells (CTLs)/live Treg cells was also significantly higher in the group receiving combination treatment than in the vehicle control and single-agent groups, strongly indicative of an ongoing anti-tumor immune response (Fig. 5J).